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Objective: To identify the proﬁling of testicular microRNAs (miRNAs) that are differentially expressed in
men with normal spermatogenesis versus Sertoli cell-only syndrome (SCOS), to predict the miRNA target
genes, and to determine the molecular networks/pathways constituted by miRNA targets.
Materials and methods: Nine obstructive azoospermic men with normal spermatogenesis and nine SCOS
men were enrolled in this study. Testicular tissues from three men with normal spermatogenesis and
three menwith SCOS were pooled respectively for miRNA microarray analysis, and the other 12 testicular
specimens were used for subsequent quantitative real-time polymerase chain reaction analysis for
validation. Moreover, the predicted targets of the differentially expressed miRNAs were identiﬁed in silico
and uploaded to Ingenuity Pathway Analysis for further network/pathway analysis.
Results: Three miRNAs that were upregulated (miR-136, miR-630, and miR-663) and seven miRNAs that
were downregulated (miR-15b, miR-18a, miR-25, miR-30a-5p, miR-34b, miR-93, and miR-126) in SCOS
specimens were identiﬁed. A total of 51 spermatogenesis-related targets were predicted in silico. Results
from quantitative reverse transcription polymerase chain reaction generally correlate with microarray
and computational analysis. Three signiﬁcant molecular networks and ﬁve canonical pathways associ-
ated with biological functions of steroidogenesis and spermatogenesis were identiﬁed.
Conclusions: Aberrant expression of 10 differentially expressed miRNAs might result in dysregulation of
steroidogenesis and spermatogenesis that may ultimately lead to SCOS.
Copyright © 2016, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Sertoli cell-only syndrome (SCOS), also known as germ cell
aplasia, is a testicular phenotype that was ﬁrst described in 1947 by
Del Castillo et al.1 The diagnosis of SCOS is based on the testicular
histopathology that exhibits a complete absence of germ cells with
only Sertoli cells lining the seminiferous tubules, reduced semi-
niferous tubule diameter, and thickened seminiferous tubule walls.
Clinically, SCOS patients present with azoospermia, normal virili-
zation, and normal to atrophic testis. Although testicular maldes-
cent, radiotherapy, chemotherapy, and genetic abnormalities have
been linked to the SCOS phenotype,2e5 the causes of SCOS at theollege of Medicine, National
Tainan 701, Taiwan.
).
ociation. Published by Elsevier Ta
, et al., Differential expression
drome, Urological Science (2molecular level remain largely unknown. Complementary DNA
microarray experiments were previously used to proﬁle gene
expression in the testes of infertile men, and unique gene expres-
sion signatures for SCOS have been reported.6,7 However, little is
known about the mechanisms involved in the regulation of gene
expression in SCOS testes.
MicroRNAs (miRNAs) ranging between 18 bp and 25 bp are
highly conserved, small, noncoding RNAs that repress expression of
target genes through messenger RNA (mRNA) cleavage, translation
repression, or chromatin modiﬁcation, and silencing.8e11 It is esti-
mated that approximately 500e1000 miRNAs are encoded in the
human genome and up to 30% of human protein-coding genes may
be miRNA targets.8,12 It has been shown that miRNAs have impor-
tant roles in diverse biological processes, including cellular devel-
opment, cell proliferation, cell differentiation, apoptosis,
organogenesis, fat metabolism, hematopoiesis, and canceriwan LLC. This is an open access article under the CC BY-NC-ND license (http://
of microRNAs and their messengerRNA targets in men with normal
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and developmental stage-speciﬁc.8
To date, there are increasing evidences showing that miRNAs
may play crucial roles in mammalian spermatogenesis. Numerous
miRNAs preferentially or exclusively expressed in mouse testes
have been identiﬁed.13,14 Mirn122a inhibits Tnp2mRNA translation
in vitro by degrading the mRNA. Tnp2 is a testis-speciﬁc genewhich
is required in chromatin remodeling during spermiogenesis.15
Chromatoid body known as a perinuclear granule in spermato-
cytes and spermatids expresses components of miRNA machinery,
indicating that miRNAs play a role in late spermatogenesis.16 Dicer1
is required for all miRNA processing, and lack of Dicer1 speciﬁcally
in germlines resulted in spermatogenic defects in multiple stages of
germ cell differentiation.17 miR-17-92 and miR-290-295 clusters
that have been shown to promote cell cycling are highly expressed
in primordial germ cell and spermatogonia, indicating that miRNA
biogenesis is also required for the proliferation or early differenti-
ation of stem cell population.18 However, all the above-mentioned
studies were performed in mice; little is known about the expres-
sions and biological functions of miRNAs in human testis.
Spermatogenesis relies heavily on post-transcriptional gene
regulation, and defects in the transcriptional regulation could
profoundly inﬂuence germ cell proliferation and differentiation,
leading to germ cell apoptosis and male infertility.19e21 Given that
miRNAs are recognized tomodulate post-transcriptional regulation
of target mRNA, we hypothesize that aberrant expression of miR-
NAs may be involved in human spermatogenic failure. This study
was conducted to identify the testicular miRNAs that are differen-
tially expressed between infertile men with normal spermatogen-
esis and SCOS, to predict their spermatogenesis-related target
genes, and to explore the molecular networks/pathways consti-
tuted by miRNA targets.
2. Materials and methods
2.1. Patients and testicular specimens
A total of 18 azoospermic men (9 men with obstructive azoo-
spermia and normal spermatogenesis and 9 men with SCOS) were
enrolled in this study. The diagnosis of azoospermia was based on
at least two separate semen analyses after centrifugation of semen
samples. None of these 18 patients had a chromosomal abnormality
or Y chromosome microdeletion. Patients with normal follicle-
stimulating hormone levels, testicular volume, and histology in
the testicular biopsy were categorized as having obstructive azoo-
spermia and normal spermatogenesis. SCOSwas deﬁned by the lack
of germ cells, with only Sertoli cells lining the seminiferous tubules
in a testicular biopsy. These patients underwent testicular biopsy
and/or testicular sperm extraction and agreed to provide a small
piece of testicular tissue for the study. All SCOS patients enrolled
were “complete” SCOS in whom failed testicular sperm extraction
and no spermatogenesis in testicular biopsies were found. Testic-
ular tissues from three men with normal spermatogenesis and
three men with SCOS were pooled, respectively, for miRNA
microarray analysis, and the other 12 testicular specimens were
used for subsequent quantitative real-time polymerase chain re-
action (qRT-PCR) for validation. This study was approved by the
Institutional Review Board of our institute (2008005) and written
informed consent was obtained from all participants.
2.2. Total RNA and miRNA isolation
Total RNA was extracted from testicular tissues homogenized in
Trizol reagent (Invitrogen, Life Technologies, Carlsbad, CA, USA).
Total RNA, including miRNA, was isolated using a miRNeasy MiniPlease cite this article in press as: Cheng YS, et al., Differential expression
spermatogenesis versus Sertoli cell-only syndrome, Urological Science (2Kit (Qiagen, Inc., Valencia, CA, USA) according to themanufacturer's
instruction. RNA concentration was assessed using the Nanodrop
ND-1000 spectrophotometer (Nanodrop Technologies, Wilming-
ton, DE, USA) and RNA quality was determined on an Agilent 2100
Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA).
2.3. miRNA microarray analysis
For miRNA proﬁling, miRNA samples extracted from three
normal spermatogenesis samples and three SCOS samples were
pooled, respectively. RNA samples were tagged with T4 RNA ligase
(GE healthcare, Chalfont Saint Giles, UK) by incubation at 16C for 2
hours. The labeled samples were hybridized to Agilent human
miRNA microarrays (version 2.0; Agilent Technologies), which
contains probes for 534 human miRNAs based on the Sanger
microRNA database version 8.2.22 Hybridizations were carried out
in duplicate. After hybridization and wash steps, the arrays were
scanned using a laser confocal scanner (G2505B; Agilent Technol-
ogies) and the images were acquired with feature extraction soft-
ware. The miRNA spot intensity values in scanned images were
determined and background-adjusted intensities were normalized
using a scatter plot. miRNAs that were differentially expressed
between normal and SCOS specimens (fold change > 2, p < 0.05)
were identiﬁed using GeneSpring 7.3.1 software (Agilent
Technologies).
2.4. qRT-PCR analysis of miRNA expression
Four miRNAs were randomly selected for transcript level
determination. Transcript levels of two upregulated (miR-136 and
miR-630) and two downregulated (miR-25 and miR-126) miRNAs
were determined using qRT-PCR in six normal and six SCOS in-
dividuals whose tissues were not used in the miRNA microarray
analysis. Ten nanograms of total RNA were reverse transcribed
using TaqMan MicroRNA Reverse Transcription Kit (Applied Bio-
systems, Foster City, CA, USA). Quantitative PCR was carried out
using TaqMan Universal PCR Master Mix and a hsa-miR assay sys-
tem on an ABI Prism 7900HT (Applied Biosystems). The reactions
were incubated in a 96-well optical plate at 95C for 10 minutes,
followed by 40 cycles of 95C for 15 seconds and 60 for 1 minute.
The transcript level of eachmiRNAwas normalized to the transcript
level of U6 small nuclear RNA. The expression of miRNA relative to
U6 small nuclear RNAwas determined using the 2△△Ct method as
described previously.23
2.5. miRNA spermatogenesis-related target prediction
The predicted targets of the differentially expressed miRNAs
were identiﬁed in silico. Two bioinformatic algorithms, TargetS-
can24 and PicTar,25 were used for computational identiﬁcation of
putative miRNA targets. Given that miRNAs potentially regulate a
large number of target transcripts, we further performed gene
ontology (GO) analysis to identify the subset of predicted targets
that are involved in spermatogenesis. Target genes were assigned
functions based on the GO categories. Genes signiﬁcantly associ-
ated with “spermatogenesis-related” GO categories, including
gametogenesis, germ cell development, male gamete generation,
spermatogenesis, spermatid development, spermatid differentia-
tion, sperm chromatin condensation, and reproductive physiology
process, were selected into our target list.
2.6. qRT-PCR analysis of target mRNA expression
Transcript levels of eight targets of miR-630 were determined
using qRT-PCR in six normal and six SCOS individuals. Total RNAof microRNAs and their messengerRNA targets in men with normal
016), http://dx.doi.org/10.1016/j.urols.2016.03.002
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sue were performed as described previously.26 The HMBS gene was
used as an endogenous control. Primer sequences are available
from the authors. The quantitative ampliﬁcation was performed in
an ABI Prism 7900HT Sequence Detection System (Applied Bio-
systems). A negative control without templatewas included in each
set of qRT-PCR assays. The reactions were incubated in a 96-well
optical plate at 95C for 10 minutes, followed by 40 cycles of 95C
for 15 seconds and 60 for 1 minute. The expression of mRNA
relative to HMBS was determined using the 2△△Ct method.2.7. Biological function, network identiﬁcation, and canonical
pathway analysis of target genes
To explore the biological functions, potential molecular net-
works, and canonical pathways these spermatogenesis-related
targets constitute, we uploaded these targets into Ingenuity
Pathway Analysis (IPA; Ingenuity Systems, www.ingenuity.com).
Each gene identiﬁer was mapped to its corresponding gene object
in the Ingenuity Pathways Knowledge Base. Fischer's exact test was
used to calculate a p value determining the probability that each
molecular and cellular function assigned to that data set is due to
chance alone. These genes, called focus genes, were overlaid onto a
global molecular network developed from information contained
in the Ingenuity Pathways Knowledge Base. Networks of these
focus genes were then algorithmically generated based on their
connectivity.
Canonical pathways analysis identiﬁed the pathways from the
IPA library of canonical pathways that were most signiﬁcant to the
data set. The signiﬁcance of the association between the data set
and the canonical pathwaywasmeasured in twoways: (1) a ratio of
the number of genes from the data set that map to the pathway
divided by the total number of genes that map to the canonical
pathway is displayed; and (2) a p value calculated using Fischer's
exact test determining the probability that the association between
the genes in the dataset and the canonical pathway is explained by
chance alone.Figure 1. Proﬁles of microRNA (miRNA) expression. (A) The heat map represents clustering
Sertoli cell-only syndrome (SCOS) testes compared with normal testes (NR); (BeE) in quan
were signiﬁcantly decreased, whereas miR-136 and miR-630 transcripts were signiﬁcantly
Please cite this article in press as: Cheng YS, et al., Differential expression
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All qRT-PCR assays described abovewere performed in triplicate
in at least three independent experiments. Data were expressed as
means ± standard error of the mean. Unpaired t-test was per-
formed to compare the transcript levels of miRNAs and mRNAs
between normal and SCOS individuals. A p value < 0.05 was
considered as signiﬁcant.3. Results
3.1. Differential expression of miRNAs between normal and SCOS
testes
Of the 534 miRNAs, a total of 64 miRNAs exhibited differential
expression with a fold change more than two-fold and a p value
less than 0.05 between normal and SCOS specimens. Twenty-three
miRNAs were upregulated (2e12.4-fold) and 41 miRNAs were
downregulated (0.004e0.49-fold) in SCOS specimens. For
increased conﬁdence, the raw intensities of hybridization signals
less than 100 were excluded. Therefore, three upregulated miRNAs
(miR-136, miR-630, and miR-663) and seven downregulated
miRNAs (miR-15b, miR-18a, miR-25, miR-30a-5p, miR-34b, miR-
93, and miR-126) in SCOS specimens were identiﬁed (Figure 1A,
Table 1).3.2. Validation of miRNA expression
To validate the microarray results, transcript levels of two
upregulated (miR-136 and miR-630) and two downregulated (miR-
25 and miR-126) miRNAs were quantiﬁed using qRT-PCR analysis.
In accordance with miRNA microarray results, the transcript levels
of miR-25 and miR-126 were signiﬁcantly decreased in the SCOS
group (Figures 1B and 1C), and the transcript levels of miR-136 and
miR-630were signiﬁcantly increased in the SCOS group (Figures 1D
and 1E).of the 10 signiﬁcantly up- and downregulated miRNAs (fold change > 2, p < 0.05) in
titative real-time polymerase chain reaction analysis, miR-25 and miR-126 transcripts
increased in SCOS versus normal testes. * p < 0.05. ** p < 0.01. *** p < 0.001.
of microRNAs and their messengerRNA targets in men with normal
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Table 1
Differentially expressed microRNAs (miRNAs) between normal (NR) and Sertoli cell-only syndrome (SCOS) testes, their chromosomal locations, and spermatogenesis-related
targets.
Human (hsa-)
miRNA
Chromosome Chromosomal
location
Mean intensity in
NR
Mean intensity in
SCOS
SCOS/NR
ratio
Spermatogenesis-related targets
hsa-miR-136 14q32.31 Intergenic 590 1321 2.238 TNP2; H1FNT; ZSCAN2; SPATA19
hsa-miR-630 15q24.1 Intergenic 573 1242 2.167 HMGCR; SPAM1; SPAG1; CRISP3; PSME4; TAC3; GNAS; SOX30
has-miR-663 20p11.1 Intergenic 590 1498 2.539 FAM12A; AKAP3; FCGRT; APOE; ACHE; STARD3; MVD
hsa-miR-15b 3q26.1 Intronic 4074 1579 0.387 DUSP13; CHEK1; NME5; ODF1; PTCH2; PPAP2A; PROK2
hsa-miR-18a 13q31.3 Intronic 738 362 0.491 ADAM28; BCL2L10; INSL3; MAK; STRBP; PRM3; SLC22A16;
PPAP2A
hsa-miR-25 7q22.1 Intronic 1467 540 0.368 MAST2; TESK1; ODF1; OAZ3
hsa-miR-30a-5p 6q13 Intergenic 1946 771 0.396 Not available
hsa-miR-34b 11q23.1 Intergenic 9889 685 0.069 BCL2L10; SERPINA5; INSL3; AZI1; SPAG11B; DZIP1L; SPATA4;
PPAP2A
hsa-miR-93 7q22.1 Intronic 925 323 0.349 ABCB9; TCFL5; MAK; STRBP; DMC1; CCNA1; CASC5
hsa-miR-126 9q34.3 Intronic 388 1776 0.457 ADAM28; CRISP1; DDX25; ELL3; SPAG11B; PRKACG
Y.S. Cheng et al. / Urological Science xxx (2016) 1e843.3. Prediction of miRNA targets
The predicted target genes for each miRNAs are shown in
Table 1. A total of 51 targets were identiﬁed; however, signiﬁcant
spermatogenesis-related targets formiR-30a-5pwere not available.
IPA suggested that these target genes were signiﬁcantly enriched
for functional annotations associated with cellular development,
cell cycle, cellular assembly and organization, cellular movement,
and cell-to-cell signaling and interaction. The genes that are
involved in each function according to IPA are shown in Table 2.Table 2
Molecular and cellular functions of 51 spermatogenesis-related target genes.
Function No. of molecule Molecule
Cellular development 24 ABCB9, ACHE, ADAM
H1FNT, INSL3, MAST
SPAG11B, STRBP, TE
Cell cycle 8 APOE, CCNA1, CHEK
Cellular assembly and organization 6 ACHE, APOE, BCL2L1
Cellular movement 11 AKAP3, APOE, GNAS
Cell-to-cell signaling and interaction 9 ACHE, ADAM28, APO
Figure 2. Quantitative real-time polymerase chain reaction analysis of microR-630 target ex
target genes between the normal (NR) and Sertoli cell-only syndrome (SCOS) testes were det
between the groups were found for SPAG1, PSME4, TAC3, and SOX30. * p < 0.05. ** p < 0.01
Please cite this article in press as: Cheng YS, et al., Differential expression
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To validate the mRNA expressions of miRNA targets between
normal and SCOS samples, miR-630 was randomly selected and the
transcript levels of its target genes were determined using qRT-PCR
(Figure 2). As shown in Figure 3, the transcript levels of SPAG1,
PSME4, TAC3, and SOX30 were signiﬁcantly decreased in the SCOS
group, whereas no signiﬁcant differences were found in the
HMGCR, SPAM1, CRISP3, and GNAS transcript levels between the
normal and SCOS group.p
28, AZI1, BCL2L10, CCNA1, CHEK1, DDX25, DMC1, DUSP13,
2, NME5, OAZ3, PRKACG, PROK2, PTCH2, SERPINA5, SOX30,
SK1, TNP2
6.26E-26
3.22E-02
1, DMC1, DUSP13, GNAS, H1FNT, PPAP2A 9.09E-05
4.61E-02
0, CHEK1, SPAM1, TNP2 1.90E-04
4.96E-02
, HMGCR, MAK, PPAP2A, PROK2, SERPINA5, SLC22A16, STRBP, TNP2 5.64E-04
1.80E-02
E, CHEK1, GNAS, PPAP2A, SERPINA5, SPAM1, TNP2 9.52E-04
4.96E-02
pression. MessengerRNA transcript levels (compared with HMBS) for eight microR-630
ermined using quantitative real-time polymerase chain reaction. Signiﬁcant differences
. *** p < 0.001.
of microRNAs and their messengerRNA targets in men with normal
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Figure 3. Network 1 identiﬁed by Ingenuity Pathway Analysis (IPA). This network consisting of 14 focus genes has an IPA score of 28. Androgen receptor is central in this network
with proposed functions of cellular development and reproductive system development and function by IPA. The focus genes are shown by shading.
Y.S. Cheng et al. / Urological Science xxx (2016) 1e8 53.5. Molecular network analysis and canonical pathway analysis
To investigate whether these predicted target genes form net-
works of interactions, we uploaded these targets for IPA analysis.
The results showed that these target geneswere overrepresented in
six IPA networks converging on cellular development, reproductive
system development and function, cell-to-cell signaling and inter-
action, cell-mediated immune response, cellular growth and pro-
liferation, amino acid metabolism, and post-translational
modiﬁcation. The top three networks with an IPA score > 20 are
shown in Figures 3e5, respectively. For canonical pathway analysis,
a total of 31 canonical pathways were identiﬁed, of which ﬁve were
signiﬁcantly (p < 0.05) associated with the data. Table 3 shows
these ﬁve pathways and their proposed functions in
spermatogenesis.
4. Discussion
Here we have presented the results of a genome-wide miRNA
proﬁling that offers a comprehensive look at miRNAs expressed in
human testes. Through microarray analysis, we identify 10 miRNAs
that are differentially expressed between normal and SCOS testes.
Three miRNAs are upregulated, while the other seven miRNAs are
downregulated in SCOS patients. Using bioinformatics and a
computational search, we predicted their target genes known to be
implicated in spermatogenesis. Results from qRT-PCR generally
correlated with microarray and computational analysis. Addition-
ally, network and canonical pathway analysis suggested severalPlease cite this article in press as: Cheng YS, et al., Differential expression
spermatogenesis versus Sertoli cell-only syndrome, Urological Science (2molecular mechanisms regulated by these target genes. We believe
that these data provide the basis for elucidating the biological ef-
fects of miRNAs in human spermatogenesis.
Although microarray analysis yields a genome-wide identiﬁca-
tion of differentially expressedmiRNAs, changes in gene expression
may vary markedly between individual patients. Moreover, it has
been shown that a piece of testicular sample may not actually
represent the histology of the entire testis due to its heterogeneous
nature of spermatogenic activity.27 In this study, testicular speci-
mens of the same histology were pooled to reduce the interper-
sonal variations and to minimize the biases of testicular biopsy.
Although it may take into account that pooling strategy can result
in a loss of sensitivity in identifying important miRNAs that have
small, but statistically signiﬁcant, changes inmiRNA expression, the
results from our pooling strategy have the potential to be applied to
most human patients.7
Our results demonstrated that miRNAs have different proﬁles in
SCOS compared with normal spermatogenesis, which are infor-
mative for reﬂecting the roles of miRNAs in spermatogenesis. Those
miRNAs whose expression is increased in SCOS may be considered
as “sterility” miRNAs. These miRNAs are thought to induce sper-
matogenic failure by negatively inhibiting genes that control germ
cell development or differentiation. By contrast, those miRNAs
whose expression is decreased in SCOS may be considered as
“fertility” miRNAs. These types of miRNAs are likely to promote
spermatogenesis. According to literature, none of the 10 miRNAs
presented here have ever been shown to be associated with
gonadal development or spermatogenesis. This may simply reﬂectof microRNAs and their messengerRNA targets in men with normal
016), http://dx.doi.org/10.1016/j.urols.2016.03.002
Figure 4. Network 2 identiﬁed by Ingenuity Pathway Analysis. This network consisting of 12 focus genes has an Ingenuity Pathway Analysis score of 25. PKA and ERK play important
roles in the formation of this network. This network has proposed functions associated with reproductive system development and function, cellular development, and organ
development. The focus genes are shown by shading.
Y.S. Cheng et al. / Urological Science xxx (2016) 1e86the limited research of miRNA in this area. Thus, our data suggest
the novel biological functions of these miRNAs in human
spermatogenesis.
Identiﬁcation of miRNA targets is essential to understand the
biological functions of miRNAs. In this study, we predicted 51
spermatogenesis-related genes targeted from the 10 miRNAs. IPA
analysis shows that individual genes were found in multiple cate-
gories of molecular and cellular functions related to cellular
development, cell cycle regulation, cell-to-cell signaling and
interaction, cellular movement, and cellular assembly and organi-
zation. Indeed, all of these functions are crucial for spermatogen-
esis. We then tested whether upregulation of miRNA is associated
with the degradation of the target transcript. miR-630 was
randomly selected, and the transcript levels of its target genes were
determined. Of the eight target genes, SPAG1, PSME4, TAC3, and
SOX30 transcripts were signiﬁcantly decreased in SCOS specimens,
suggesting that miR-630 might induce transcript degradation of
these genes. In contrast, transcript levels of the HMGCR, SPAM1,
CRISP3, and GNAS genes are not different between normal and SCOS
testes, suggesting that miR-630 might lead to the accumulation of
target mRNAs in the P- or GW-bodies,28,29 isolating mRNAs from
translation. Thus, only signiﬁcant changes in the protein level, but
not in RNA level, are found.30e32 However, given that each mRNA
may be controlled by several miRNAs or transcriptional factors, it isPlease cite this article in press as: Cheng YS, et al., Differential expression
spermatogenesis versus Sertoli cell-only syndrome, Urological Science (2also possible that miR-630 can bind the complementary binding
sites within these target genes but play little role in controlling the
gene expression. Therefore, our results raise the importance of
experimental validation of miRNA/mRNA interaction in deter-
mining the effect of miRNA on target's expression.
In this study, functional analysis identiﬁed three high score
networks containing target genes linking to SCOS. Network 1 pri-
marily centers on the androgen receptor gene. It is well known that
androgen is essential for fetal and pubertal gonadal development
and thatmutation/polymorphism of the androgen receptor gene can
cause a wide spectrum of androgen insensitivity syndromes, from
ambiguous genitalia to idiopathic male infertility.33 Network 2 is
identiﬁed around PKA and ERK genes. Cyclic AMP-PKA pathway is
required for steroidogenic acute regulatory protein synthesis and
steroidogenesis,34 and ERK has recently been shown to regulate
steroidogenic acute regulatory protein expression in conjunction
with the PKA and PKC pathways,35 suggesting that molecules
involved in this network are essential for testicular steroidogenesis.
Network 3 shows a lot of activity around transforming growth
factor-b1 that is a multifunctional cytokine. A number of studies
have suggested that transforming growth factor-b1 plays crucial
roles in the testicular development during puberty, in regulation of
spermatogenesis and steroidogenesis.36,37 Consistent with the
ﬁndings from network analysis, the canonical pathway analysisof microRNAs and their messengerRNA targets in men with normal
016), http://dx.doi.org/10.1016/j.urols.2016.03.002
Figure 5. Network 3 identiﬁed by Ingenuity Pathway Analysis. This network consisting of 10 focus genes has an Ingenuity Pathway Analysis score of 20. This network shows a lot of
activity around transforming growth factor-b1, suggesting roles in cell-to-cell signaling and interaction, cell-mediated immune response, cellular growth, and proliferation. The
focus genes are shown by shading.
Table 3
Signiﬁcant canonical pathways of target genes and their proposed roles in spermatogenesis.
Canonical pathway p Proposed role in spermatogenesis
Biosynthesis of steroid 3.64E-03 Steroidogenesis
Sonic-hedgehog signaling 4.56E-03 M-phase cell cycle progression, transcriptional regulation, cell proliferation
cAMP-mediated signaling 1.68E-02 Regulation of transcription, Steroidogenesis, apoptosis
LXR/RXR activation 2.51E-02 Cholesterol metabolism, inﬂammatory mediation
Aryl-hydrocarbon receptor signaling 4.8E-02 Cell cycle progression, cell proliferation, apoptosis
LXR ¼ liver X receptor; RXR ¼ retinoid X receptor.
Y.S. Cheng et al. / Urological Science xxx (2016) 1e8 7revealed that steroid biosynthesis-related pathways and cell cycle-
related pathways are the most signiﬁcant signaling pathways
modulated by these target genes. Thus, the data suggest that
miRNAs might regulate diverse functions in multiple aspects of
spermatogenesis and steroidogenesis. Dysregulation of thesePlease cite this article in press as: Cheng YS, et al., Differential expression
spermatogenesis versus Sertoli cell-only syndrome, Urological Science (2miRNA can result in spermatogenic failure that may ultimately lead
to SCOS.
Our data provide the potential causative roles of deregulated
miRNA processes in human spermatogenesis. A better under-
standing of these networks and pathways will bring us closer to anof microRNAs and their messengerRNA targets in men with normal
016), http://dx.doi.org/10.1016/j.urols.2016.03.002
Y.S. Cheng et al. / Urological Science xxx (2016) 1e88understanding of the molecular mechanisms underlying the causes
of SCOS. We are currently using luciferase reporter assay, a gene-
silencing technique, as well as rescue assay to validate speciﬁc
miRNA targets. If the biological functions and the relevant signal
pathways of miRNAs are extensively studied, we expect that the
miRNA proﬁles may aid in the diagnosis of male infertility.
Furthermore, antisense oligonucleotides complementary to miR-
NAs (antagomirs) or synthetic miRNAs (agomirs) can be generated.
Given that therapeutic antagomir has been successfully used in
nonhuman primates,38 activation or silencing of miRNAs might
become a therapeutic strategy for male infertility treatment in the
future.
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